ViaCell, Inc. to Announce Second Quarter Results on August 9, 2005

Related News: Cord Blood Stem Cells, Stem Cell Companies

CAMBRIDGE, Mass., Aug. 2 /PRNewswire-FirstCall/ -- ViaCell, Inc. (Nasdaq: VIAC - News) announced today that it will report second quarter 2005 results on Tuesday August 9, 2005 at 8:30 a.m. Eastern Time. Following the announcement, ViaCell senior management will host a conference call at 10:00 a.m. Eastern Time to discuss operational and financial results and the Company's outlook for the future.

The conference call will be simultaneously webcast and can be accessed from ViaCell's website at http://www.viacellinc.com. The live audio of the conference call is also accessible via telephone to investors, members of the news media and the general public by dialing either (800) 819-9193 (United States and Canada) or (913) 981-4911 (International) and typing in the passcode 6530848.

An archived replay of the webcast will be available via ViaCell's website until September 9, 2005. The replay will also be available via telephone by dialing (888) 203-1112 (United States and Canada) or (719) 457-0820 (International) and typing in the passcode 6530848 from August 9, 2005 at 1:00 p.m. Eastern Time until September 9, 2005.

About ViaCell

ViaCell, Inc. is a clinical-stage biotechnology company dedicated to enabling the widespread application of human cells as medicine. The Company is developing a pipeline of proprietary product candidates intended to address cancer, cardiac disease, diabetes and infertility. ViaCell's portfolio of proprietary technologies includes Selective Amplification technology and USSCs. The Company's lead cord-blood derived stem cell therapy product candidate, CB001, is currently in a Phase I clinical trial. ViaCell also offers expecting families the option of preserving their baby's cord blood stem cells through its Viacord business.

Corporate Contact
Stephen G. Dance
ViaCell, Inc.
(617) 914-3535
sdance@viacellinc.com

Investors:
Clay Kramer (ckramer@burnsmc.com)
Media:
Justin Jackson (jjackson@burnsmc.com)
Burns McClellan, Inc.
(212) 213-0006



Posted on August 9, 2005 05:15 PM

 
Stem Cell Research Site Map